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Abstract
Background: Glycated haemoglobin (HbA1c) is often used as one of the indicators to measure the quality of
diabetes care. Complete registration is difficult to obtain. This study investigated the reasons for missing HbA1c
measurements.
Findings: HbA1c measurements for 1485 patients with diabetes mellitus type 2 who were attended by 19 general
practitioners at 4 primary care health centres in south-east Amsterdam were studied. HbA1c measurements were
missing for 356 (23.9%) of the patients. The main reason stated in 50% of the cases was that the patient was under
specialized care.
Conclusions: The general practitioners provided multiple reasons for the missing HbA1c measurements. This study
provides insight into why HbA1c measurements were not present in the patients’ electronic medical record.
Background
Dutch guidelines for GP practice contain systematic pre-
scriptions for diabetes type 2 care that include quarterly
monitoring of the lifestyle of diabetes patients by practice
nurses and annual evaluations of optimal glycaemic con-
trol by GPs. The guidelines emphasize annual evaluation
of micro-vascular complications, as well as cardiovascular
risk factors and vascular damage [1]. The identification of
barriers impeding adherence to guidelines has proven a
necessary condition for the further improvement of care
strategies [2-4]. The measurement of glycated haemoglo-
bin (HbA1c) is an essential part of the annual evaluation of
glycaemic control for patients with diabetes type 2 [1,5].
In several countries (e.g. the UK and the Netherlands),
GP practices are required to obtain a certain number of
measurements and outcomes as guideline-based diabetes
care indicators for pay-for-performance purposes [6-8].
Although indicators in the Netherlands are standardized
nationally [9,10], performance indicators are organized in
local settings based on contracts with health insurance
companies. The effects of quality and outcome frame-
works have been evaluated and described [11,12],
however, these studies do not provide reasons for missing
indicator measurements.
To improve understanding regarding non-adherence
to the guideline-based care, we formulated the following
research questions:
1) How complete are HbA1c measurement data?
2) Which factors can explain missing data?
Methods
Setting
We used a subset of data from the GP registration net-
work of the department of General Practice of the Aca-
demic Medical Center-University of Amsterdam (AMC).
The network uses routinely recorded data in electronic
medical records for research purposes. Diagnoses are
coded according to the International Classification of
Primary Care (ICPC). Four health centres in south-east
Amsterdam participate in this network. At these health
centres, 22 GPs and 8 practice nurses provide primary
care to 35,700 patients. The four centres belong to the
same umbrella organization (GAZO), which signs the
pay-for-performance contract with a health insurance
company for standard, structured multidisciplinary dia-
betes care under GP coordination. Since 2007, the regis-
tration of diabetes care indicators has been implemented
within this network as part of a disease management
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tration was implemented in order to enhance efforts to
improve the quality of diabetes care and to provide an
infrastructure for diabetes-related research. All of the
health centres use the same computerized patient elec-
tronic medical record system (MIRA). Patients with
diagnosed diabetes type 2 are coded ICPC T90.2 in their
electronic medical records. Only patients whose were
under structural care by the GPs were included in our
study.
Following regular care, patients visit their health cen-
tres every three months for lifestyle consultations, medi-
cation evaluations and evaluations of their well-being,
and annually for comorbidity screening and therapy
planning. A minimum of two weeks before the annual
visits, HbA1c blood levels are measured in a blood
laboratory. Results of these measurements are forwarded
electronically to the patients’ electronic medical records.
Identification of reasons for non-registration
The number of practice-based measurements of the dia-
betes-care indicator HbA1c was calculated over the year
2007. This 12-month period is in line with the regional
pay-for-performance contract. Nineteen of twenty-two
practices at the four health centres agreed to participate in
this study. The number of measurements was presented to
these practices during feedback sessions. After the ses-
sions, each GP was given a form with the numbers refer-
ring to patients for whom HbA1c measurements were
missing. The GPs were asked to state the main reason for
each missing HbA1c measurement.
The stated reasons were collected and grouped into
categories by one of the authors (HJB). This grouping
was presented to the other authors. Disagreements were
resolved through discussion.
Results
In 2007, 1485 patients diagnosed with diabetes type 2 vis-
ited the participating GPs (n = 19). For 356 (23.9%) of
these patients, HbA1c measurements were absent over a
12-month calendar year period. Table 1 lists the reasons
for missing HbA1c measurements, grouped into eight
categories. In 50% of the cases, the stated reason is that
the patient is under treatment by a specialist (reason 1).
Reasons 2 and 3 (both 7%) are inherent to the chosen
timeframe of one calendar year. Reason 4 (3%) is caused
by the administrative process. Reasons 5 and 6 (8% and
3%, respectively) are patient related. The missing HbA1c
measurements attributed to reason 7 (7%) are due to
misclassification of the diagnoses of patients with pre-
diabetes conditions (hyperglycaemia, gestational
diabetes). Reason 8 (6%) refers to practical problems in
performing regular patient monitoring. Reason 9 (6%)
comprised ‘other’ reasons (e.g. dementia or recent
registration at the practice). In 3% of the cases, the GP
provided no reason. The practices of the non-participat-
ing GPs (n = 3) did not have higher rates of missing
HbA1c measurements (mean: 21%, range: 15-32%) than
did the participating GP practices (mean: 25%, range:
13-50%).
Discussion
The GPs provided multiple reasons for missing HbA1c
measurements. The majority of the missing values are
due to patients being in specialized care. A true reflec-
tion of the well-being of a population calls for a set of
measurements that is as complete as possible, regardless
of whether the goal is to obtain data for performance
indicators or to conduct scientific research.
Our study provides insight into why HbA1c measure-
ments were not present in the patients’ electronic medical
records when calculating the percentage of available mea-
surements over a 12-month period. Several factors under-
lie the stated reasons for the missing measurements.
Evidence emerged to suggest discrepancies in the diagnos-
tic coding of patients with hyperglycaemia or gestational
diabetes (reason 7). In some cases, these conditions were
registered as diabetes type 2, which prompted the moni-
toring system to generate reminders to provide these
patients with structural screening for diabetes type 2. The
practical implementation of a guideline should be well
supported by a logistical system for regular patient
appointments. In some cases, this system did not work
properly (reason 8). Lack of patient compliance with struc-
tural care was absent in some cases (reason 5 and 6). In
other cases, there were no clear agreements concerning
changes in a patient’s data (e.g. due to death or relocation)
and how these changes should be recorded (reason 4). If
the focus of data collection is a 12-month period, as pre-
scribed by the guideline, newly diagnosed patients and
patients whose HbA1c measurements were made just out-
side the 12-month period fall outside the scope of this
registration. Also, patients who are under specialized care
but not defined as such also fall outside this scope. Due to
the use of different electronic medical systems, the health
records of patients who are under specialized diabetes care
are not uploaded into the GP system. There is currently
no way for GP practices or researchers to extract the data
that are necessary for monitoring these patients. Because
reasons 1 to 4 are currently inevitable, efforts to improve
the registration of HbA1c measurements will not be able
to increase the percentage to more than 84% of all diabetic
type 2 patients registered at GP practices.
Since the implementation of the Quality and Outcome
Framework in the UK, several studies have been pub-
lished describing evaluations [11,12] that were carried
out in order to optimize the effects of the framework.
Improvements in care, however, depend upon the ability
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as the underlying causes for missing registrations [2].
Recent description of diabetes process analysis for one
UK practice provided neither a description nor an expla-
nation for the missing data [13]. Overcoming barriers to
registration may improve both adherence to the guide-
line and HbA1c measurements.
This study had several limitations. The results are
based on data provided by 19 of 22 GPs at 4 health cen-
tres, with ‘No time available’ noted as a reason for non-
participation. Nonetheless, the HbA1c registrations of the
non-participating practices did not differ from those of
the participating practices. In addition, our results are
built on a single cross-section of data concerning a
patient population living in a limited geographical area;
the south-east Amsterdam. The population in this area
comprises patients of various ethnic backgrounds and a
high percentage of low-income groups. In 2009, 72% of
this population was made up of first or second-genera-
tion migrants (i.e. either they or at least one of their par-
e n t sw e r en o tb o r ni nt h eN e t h e r l a n d s )[ 1 4 ] ,w h i l s t
countrywide this was 20% [15]. In 2006, 32% of the
households were in the lowest income group [14]. These
characteristics might explain why the percentage of
HbA1c measurements not comparable to corresponding
percentages observed in the UK (e.g. 94% described by
Tahrani [13]) after the implementation of the Quality
and Outcome framework. However, the percentage is
comparable to that observed in other parts of the Nether-
lands (e.g. 84% described by Voorham for the Dutch
GIANTT project [16]). Finally, GP care in the Nether-
lands is arranged differently than it is in other countries,
thus possibly influencing the relative availability of
HbA1c measurements.
Conclusions
We believe that GPs in several countries will recognize
the various reasons we have enumerated for missing
HbA1c measurements and the existence of barriers to
registration. This information will be useful to GPs, not
only in their efforts to implement quality procedures
related to diabetes, but also as a way of showing insur-
ance companies why it is not always possible to reach
the required minimum registration threshold. The lim-
itations we have identified can be used to improve
guideline adherence and the quality of indicator
registration.
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